Target intelligence / Profile preview

Intestinal fluid secretion via osmotic action

Molecular classification
Other (Physiological process), Other (Mechanism of action)
01

Overview

Intestinal fluid secretion via osmotic action is a physiological process rather than a specific molecular target such as a receptor or enzyme (StatPearls, NBK537246). It occurs when non-absorbable or poorly absorbed solutes remain within the intestinal lumen, creating an osmotic gradient that draws water from the intestinal mucosa and interstitial space into the gut (Merck Manual, 2023). This mechanism is the fundamental principle behind osmotic laxatives, which are used to increase stool frequency and soften consistency in patients with constipation (PubMed, 28407155). While therapeutically useful, this process can also be pathological, leading to osmotic diarrhea in conditions like carbohydrate malabsorption or lactose intolerance (NIH, 2022). Drugs that leverage this action, such as polyethylene glycol and magnesium-based salts, do not typically interact with a specific protein but instead alter the physical-chemical environment of the bowel. Clinical management requires monitoring for potential electrolyte disturbances and dehydration, particularly in patients with renal or cardiac impairment (StatPearls, NBK537246).

Other names
Osmotic laxative effectOsmotic diarrheaIntraluminal osmotic water retentionOsmotic fluid shift
02

Mechanism of action

The presence of non-absorbable, osmotically active solutes in the intestinal lumen creates an osmotic gradient that draws water from the intracellular and interstitial spaces into the gut lumen, increasing stool volume and stimulating peristalsis (StatPearls, NBK537246).

03

Biological functions

Fluid homeostasisIntestinal transit regulationOsmoregulationExcretion
04

Disease associations

ConstipationOsmotic diarrheaLactose intoleranceMalabsorption syndromesShort bowel syndrome
05

Safety considerations

Electrolyte imbalance (e.g., hypermagnesemia, hyperphosphatemia)DehydrationRenal impairment (contraindication for certain osmotic salts)Abdominal crampingFlatulence
06

Interacting drugs

Polyethylene glycol (PEG 3350)

6 more in the full profile.

07

Biomarkers

Fecal osmotic gap (PubMed, 28407155)Bristol Stool Scale (StatPearls, NBK537246)Stool water contentSerum electrolyte levels (sodium, potassium, magnesium)

Beyond the preview

Go deeper on Intestinal fluid secretion via osmotic action.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal fluid secretion via osmotic action.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call